Managing the Older Adult Patient With HIV 2016
DOI: 10.1007/978-3-319-20131-3_10
|View full text |Cite
|
Sign up to set email alerts
|

Antiretroviral Treatment in Older Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 80 publications
0
1
0
Order By: Relevance
“…Based on the presence of comorbidities, polypharmacy, and pharmacokinetic and pharmacodynamic alterations associated with age, Guaraldi [ 81 ] further expanded considerations in the choice of antiretroviral drug for these patients, with an emphasis on integrase inhibitors [ 82 ], owing to their tolerability, low toxicity, and low number of drug-drug interactions. However, given that multiple treatment options are available, treatment should be prescribed on an individual basis, informed by underlying resistance, comorbidities, and patient and provider preference.…”
Section: Clinical Considerations For the Care Of Older Hiv-infectementioning
confidence: 99%
“…Based on the presence of comorbidities, polypharmacy, and pharmacokinetic and pharmacodynamic alterations associated with age, Guaraldi [ 81 ] further expanded considerations in the choice of antiretroviral drug for these patients, with an emphasis on integrase inhibitors [ 82 ], owing to their tolerability, low toxicity, and low number of drug-drug interactions. However, given that multiple treatment options are available, treatment should be prescribed on an individual basis, informed by underlying resistance, comorbidities, and patient and provider preference.…”
Section: Clinical Considerations For the Care Of Older Hiv-infectementioning
confidence: 99%